Original Investigation
Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement Study

https://doi.org/10.1053/j.ajkd.2017.06.008Get rights and content

Background

Several electronic alert systems for acute kidney injury (AKI) have been introduced. However, their clinical benefits require further investigation.

Study Design

Before-and-after quality improvement study.

Setting & Participants

A tertiary teaching hospital in Korea, which adopted an AKI alert system on June 1, 2014. Before and after launch of the alert system, 1,884 and 1,309 patients with AKI were included in the usual-care and alert groups, respectively.

Quality Improvement Plan

Implementation of an AKI alert system through which clinicians could generate automated consultations to the nephrology division for all hospitalized patients.

Outcomes

Primary outcomes included overlooked AKI events, defined as not measuring the follow-up creatinine value, and the consultation pattern of clinicians. Secondary outcomes were severe AKI events; AKI recovery, defined based on the creatinine-based criterion; and patient mortality.

Measurements

ORs for events of overlooked AKI, early consultation, and severe AKI were calculated with logistic regression. AKI recovery rate and patient mortality were assessed using Cox regression.

Results

After introduction of the alert system, the odds of overlooked AKI events were significantly lower (adjusted OR, 0.40; 95% CI, 0.30-0.52), and the odds of an early consultation with a nephrologist were greater (adjusted OR, 6.13; 95% CI, 4.80-7.82). The odds of a severe AKI event was reduced after implementation of the alerts (adjusted OR, 0.75; 95% CI, 0.64-0.89). Furthermore, the likelihood of AKI recovery was improved in the alert group (adjusted HR, 1.70; 95% CI, 1.53-1.88). Mortality was not affected by the AKI alert system (adjusted HR, 1.07; 95% CI, 0.68-1.68).

Limitations

Possible unreported differences between the alert and usual-care groups.

Conclusions

Implementation of the AKI alert system was associated with beneficial effects in terms of an improved rate of recovery from AKI. Therefore, widespread adoption of such systems could be considered in general hospitals.

Section snippets

Ethics Considerations

The Food and Drug Administration of Korea approved the development and launch of the AKI alert system (KCT0002010). The Institutional Review Board (IRB) of Seoul National University Bundang Hospital approved the study (IRB number: B-1402/238-006) and waived the need for informed consents. This study was conducted in accordance with the principles of the Declaration of Helsinki.

Study Design and Study Population

This before-and-after study was conducted at a tertiary referral hospital in Korea with more than 1,000 general

Study Population

Figure 1 shows the study flow diagram. There were 21,554 and 25,487 index admission cases in the historical and study cohorts, respectively. After excluding cases of death on the day of AKI, 1,739 patients had AKI events after the launch of the alert, and following the same criteria, 2,189 patients were identified as having AKI events in the historical cohort. Finally, after additional exclusion, we included 1,884 patients in the usual-care group and 1,309 patients in the alert group.

Baseline Characteristics

There were

Discussion

In our hospital, we launched an electronic AKI alert system, which linked a surveillance system to direct intervention by nephrologists. After the system was introduced, clinicians were more likely to monitor patients with AKI events and earlier involvement by nephrologists was observed. Moreover, we observed a significant improvement in AKI recovery rate and reduction of severe AKI events. Our study is the first to demonstrate an association of improved clinical outcomes with use of an

Acknowledgements

We acknowledge Sung Woo Lee, MD, Eulji General Hospital, Seoul, and Mi-yeon Yu, MD, Seoul National College of Medicine, Kyuseok Kim, MD, PhD, Seoul National University Bundang Hospital, for assistance in designing the alert system; Anna Lee, MD, Seoul National University Bundang Hospital, for assistance in data management; and Hyunjin Cho, RN, Seoul National University Bundang Hospital, for data acquisition. We also appreciate the advice from the Seoul National University Bundang Hospital

References (30)

  • G.M. Chertow et al.

    Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

    J Am Soc Nephrol

    (2005)
  • E.M. Levy et al.

    The effect of acute renal failure on mortality. A cohort analysis

    JAMA

    (1996)
  • A.X. Garg et al.

    Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial

    JAMA

    (2014)
  • M.J. Ragaller et al.

    Volume replacement in critically ill patients with acute renal failure

    J Am Soc Nephrol

    (2001)
  • P.S. Parfrey et al.

    Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

    N Engl J Med

    (1989)

    • Cited by (88)

    • Early recognition and prevention of acute kidney injury in hospitalised children

      2023, The Lancet Child and Adolescent Health

    • Nephrotoxins and acute kidney injury – The consensus of the Taiwan acute kidney injury Task Force

      2022, Journal of the Formosan Medical Association

    • A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conference

      2024, Pediatric Nephrology

    • Automated Electronic Alert for the Care and Outcomes of Adults with Acute Kidney Injury: A Randomized Clinical Trial

      2024, JAMA Network Open

    • Utilizing electronic medical records alert to improve documentation of neonatal acute kidney injury

      2024, Pediatric Nephrology

    • Adherence to guidelines for management of acute kidney injury

      2024, Journal of International Medical Research
    View all citing articles on Scopus

    Complete author and article information provided before references.

    Authors’ Full Names and Academic Degrees: Sehoon Park, MD, Seon Ha Baek, MD, Soyeon Ahn, PhD, Kee-Hyuk Lee, MD, Hee Hwang, MD, Jiwon Ryu, MD, Shin Young Ahn, MD, PhD, Ho Jun Chin, MD, PhD, Ki Young Na, MD, PhD, Dong-Wan Chae, MD, PhD, and Sejoong Kim, MD, PhD.

    Authors’ Contributions: Study concept and design: SP, SHB, SYA, JR, SK; acquisition, analysis, or interpretation of data: SP, SA, JR, SYA, SK; statistical analysis: SP, SYA, SA; funding obtainment: JR, HH, K-HL, HJC, KYN, SK; administrative, technical, or material support: K-HL, HH; study supervision: KYN, D-WC, SK. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

    Support: This study was supported by a Young Investigator Research Grant (number 06-2014-151) from the Korean Society of Nephrology (Kyowa Hakko Kirin 2014), a grant from the Seoul National University Bundang Hospital Research Fund (number 02-2014-058), and a grant from the Korea Research Fund from Ministry of Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (number HI16C2221). The sponsors of this study played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.

    Financial Disclosure: The authors declare that they have no other relevant financial interests.

    View full text
    © 2017 by the National Kidney Foundation, Inc.